5-FU	5-fluorouracil
AML	Acute myeloid leukemia
ALL	Acute lymphoblastic leukemia
ATT	Androgen receptor axis-targeted therapies
BSI	Bloodstream infections
CPIs	Checkpoint inhibitors
CRC	Colorectal cancer
CTLA-4	Cytotoxic T-lymphocyte-associated protein 4
CV	Coefficient of variation
dHPLC	Denaturing high-performance liquid chromatography
FISH	Fluorescent in situ hybridization
FMT	Fecal microbiota transplantation
GNRH	Gonadotropin-releasing hormone
GPCR	G protein-coupled receptor
I	Ipilimumab
IN	Ipilimumab + nivolumab
LDA	Linear discriminant analysis
N	Nivolumab
NET	Neuroendocrine tumors
NSCLC	Non-small cell lung cancer
OTU	Operational taxonomic unit
OS	Overall survival
P	Pembrolizumab
PCA	Principal component analysis
PCoA	Principal coordinate analysis
PCR-DGGE	Polymerase chain reaction denaturing gradient gel electrophoresis
PD-1	Programmed cell death protein 1
PFS	Progression free survival
PICOS	Participants, interventions, comparators, outcome measures, study design
qPCR	Quantitative polymerase chain reaction
QUIPS	Quality In Prognosis Studies
RECIST	Response evaluation criteria in solid tumors
RCC	Renal cell carcinoma
SCFA	Short-chain fatty acids
WMGS	Whole metagenome sequencing